Frequency and Predictors of Relapses following SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis: Interim Results from a Longitudinal Observational Study

por Frahm, Niklas, Fneish, Firas, Ellenberger, David, Haas, Judith, Löbermann, Micha, Peters, Melanie, Pöhlau, Dieter, Röper, Anna-Lena, Schilling, Sarah, Stahmann, Alexander, Temmes, Herbert, Paul, Friedemann, Zettl, Uwe Klaus
Publicado 2023

SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study

por Frahm, Niklas, Fneish, Firas, Ellenberger, David, Haas, Judith, Loebermann, Micha, Parciak, Tina, Peters, Melanie, Pöhlau, Dieter, Rodgers, Jeff, Röper, Anna-Lena, Schilling, Sarah, Stahmann, Alexander, Temmes, Herbert, Zettl, Uwe K., Middleton, Rodden M.
Publicado 2022

How is and how should healthcare for people with multiple sclerosis in Germany be designed?–The rationale and protocol for the mixed-methods study Multiple Sclerosis–Patient-Orient...

por Krüger, Kathrin, Fricke, Lara Marleen, Dilger, Elise-Marie, Thiele, Annett, Schaubert, Kristina, Hoekstra, Dyon, Heidenreich, Fedor, Brütt, Anna Levke, Stahmeyer, Jona T., Stahmann, Alexander, Röper, Anna-Lena, Kubiak, Klaus-Peter, Hemmerling, Melissa, Grau, Anja, Eichstädt, Kerstin, Behrens, Sabine, Krauth, Christian
Publicado 2021